Megan Adediran: Creating Road to Clot to Close the Gap in Undiagnosed Bleeding Disorders in Nigeria
Megan Adediran, Executive Director of the Haemophilia Foundation of Nigeria, shared a post on LinkedIn:
“Global prevalence estimates suggest that tens of thousands of Nigerians may be living with undiagnosed bleeding disorders.
Many endure avoidable pain, disability, and loss simply because the right questions were never asked and the right tests were never done.
This gap is what led the Haemophilia Foundation of Nigeria to create Road to Clot.
Through Road to Clot, we take screening beyond hospital walls and into communities. Using mobile outreach, we assess bleeding history, carry out basic clotting tests, provide counselling, and link individuals and families to appropriate care.
Our aim is straightforward and urgent: to find people early, reduce preventable suffering, and build a clear pathway into care and reliable data for action.
We are calling on partners across government, healthcare, faith-based institutions, and civil society to stand with us. Awareness saves lives. Early diagnosis saves lives.
This is the path we have chosen.
This is the Road to Clot”
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients